Bioeq Ag Is A Swiss Biopharmaceutical Joint Venture Based In Zugswitzerlandformed By Polpharma Biologics Group And Formycon Agthe Company Focuses On The Developmentlicensingand Commercialization Of Biosimilar Productsaiming To Provide Affordable Biopharmaceutical Solutions The Company Specializes In Creating Biologics That Are Comparable To Existing Reference Productsbioeq Ag Offers Licensing Opportunities For Its Biosimilar Portfolio And Supports Global Market Entry For These Productsit Also Assists Clients With Regulatory Affairs And Ensures Quality Control To Meet International Manufacturing And Safety Standardsone Of Its Key Products Is A Biosimilar Version Of Ranibizumabdesigned To Treat Retinal Conditions Like Age Related Macular Degenerationbioeq Ag Collaborates With Pharmaceutical Distributorshealthcare Providersand Regulatory Bodies Worldwideleveraging The Expertise Of Its Parent Companies To Enhance Its Offerings In The Biopharmaceutical Sector
